IRVINE, Calif. - ReShape Lifesciences (NASDAQ:RSLS), a micro-cap company with a market capitalization of $2.69 million specializing in weight loss and metabolic health solutions, has been granted a ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...

ReShape Lifesciences (RSLS) announced that the Company was granted a key international patent from the State of Israel Patent Office for its ...

Motassembelah Abuzayed was injured in northern Gaza in October 2023, losing his left arm and several fingers on his right ...

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

As for any painful diagnosis, treatment options are imperfect ... sensitivity and specificity for diagnosing trigeminal nerve root entry zone impingement with confidence. While emerging imaging ...

Yoga can help relieve sciatica pain and even prevent it from returning, as it helps improve spinal alignment and release tension. Here are the poses that help the most.

Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

World Cancer Day, observed every 4 February, aims to raise awareness about cancer, encourage prevention and look at ways of improving a cancer patient’s quality of life. Interventional radiology plays ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...